[1]
“Guiding the Treatment of Hidradenitis Suppurativa: A Role for Therapeutic Drug Monitoring”, acmcr, vol. 6, no. 1, pp. 11–16, Jan. 2022, Accessed: Sep. 11, 2026. Available: https://fortunejournals.org/ojs/index.php/acmcr/article/view/22573